Bulavin Dv

717 citations
6 papers · 585 indexed · 1 hit paper · h-index 3
Co-authors
Smirnov Vv
Topics
Cancer-related Molecular Pathways (5 papers)Cell death mechanisms and regulation (2 papers)Cancer, Hypoxia, and Metabolism (1 paper)
Journals
The EMBO JournalPubMed
Partner nations
RussiaUnited States

In The Last Decade

Bulavin Dv

5 papers receiving 576 citations

Hit Papers

Phosphorylation of human p53 by p38 kinase coordinates N-...19992026200820171999100200300400500

Peers

Bulavin Dv
Comparison fields: 5 of 70
  • Molecular Biology 471
  • Oncology 284
  • Cancer Research 92
  • Cell Biology 73
  • Physiology 49
Replace Fedor Nikulenkov with:
Fedor Nikulenkov Sweden
Walid Mahfouf France
Kangjian Wu United States
Isabelle Lefrère France
Rhonda Croxton United States
Aneta Swat Spain
Marinella Klein Germany
Boxiao Ding United States
Kamila Burdová Czechia
R Watts United States
Bulavin Dv relative to Fedor Nikulenkov Sweden Fedor Nikulenkov's profile →
Citations per field
00.5×1.7×
Fedor Nikulenkov · 1×
Citations per year

Countries citing papers authored by Bulavin Dv

Since Specialization
Citations

This map shows the geographic impact of Bulavin Dv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bulavin Dv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bulavin Dv more than expected).

Fields of papers citing papers by Bulavin Dv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bulavin Dv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bulavin Dv. The network helps show where Bulavin Dv may publish in the future.

Co-authorship network of co-authors of Bulavin Dv

This figure shows the co-authorship network connecting the top 25 collaborators of Bulavin Dv. A scholar is included among the top collaborators of Bulavin Dv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bulavin Dv. Bulavin Dv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1
[Anti-apoptotic and antiproliferative effect of bcl-2 gene transferred to E1A+cHa-ras-transformed cells].
1
2
[Oncoproteins E1Aad5 interact with universal inhibitor of cyclin-dependent kinases p21/waf-1 and inhibit its activity in E1A + cHa-ras transformants].
2
3
Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiationbreakdown →
579
4
[Function of the p53-pRb-dependent path after exposure to DNA damaging agents in rats embryonal fibroblast cells, transformed by E1A and Ha-Ras oncogenes].
1
5
[Apoptotic cell death in rat embryo fibroblasts transformed by EiA + cHa-RAS oncogenes after gamma irradiation].
0
6
[The subcellular distribution of the glutathione system enzymes in the brain tissue of the rat].
2

About Bulavin Dv

Bulavin Dv is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 6 papers that have together received 585 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cell death mechanisms and regulation (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (284 citations), Molecular Biology (471 citations) and Cancer Research (92 citations). Bulavin Dv has collaborated with scholars based in Russia and United States. Frequent co-authors include Smirnov Vv. Their work appears in journals such as The EMBO Journal and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026